CANCER AWARENESS THROUGH RESEARCH … - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

Jill Porcellato

Phone

9522217432

Tax Period

2024-07-01 to 2025-06-30

CANCER AWARENESS THROUGH RESEARCH AND EDUCATION CARE, founded in 2005, is a small nonprofit in the Medical Research sector that reported $868K in total revenue in fiscal year 2024.

Mission

CARE PROMOTES AWARENESS ABOUT CANCER TREATMENT AND PREVENTION THROUGH EDUCATIONAL FORUMS AND SEMINARS AND RAISES MONEY TO PROVIDE GRANTS TO FUND INNOVATIVE NEW CANCER RESEARCH PROJECTS AND CLINICAL TRIALS PRIMARILY IN THE GREATER PHOENIX METROPOLITIAN AREA AND ARIZONA MORE BROADLY.

Program Service Accomplishments

Program 1

Expenses: $748,000

During the fiscal year ended June 30, 2025, Cancer Awareness through Research and Education (CARE) approved total research funding of $786,000, which included $38,000 in direct donor-designated...

During the fiscal year ended June 30, 2025, Cancer Awareness through Research and Education (CARE) approved total research funding of $786,000, which included $38,000 in direct donor-designated contributions.Per the allocation approved by the CARE Funding Committee and Board of Directors, contributions were designated as follows:$397,000 to Mayo Clinic, including $23,000 in direct donations.$389,000 to HonorHealth Research Institute, including $15,000 in direct donations.Payments of $374,000 were issued to each institution during the fiscal year to fulfill these commitments.Funds provided to Mayo Clinic were restricted to two approved research projects:1.Pathogenesis of MYC-Overexpressing Acute Leukemia identifying high-risk patients and developing more effective treatments.2.Fast Neoepitope Prioritization and RNA Nanoparticle Dendritic Cell Vaccines for Solid Tumors advancing personalized cancer vaccine development.Funds provided to HonorHealth Research Institute were restricted to two funding requests encompassing four interrelated research projects:1.Plant EV, Nanoparticle Silicon, VFI Studies2.Uveal Melanoma ResearchBoth Mayo Clinic and HonorHealth Research Institute are required to submit annual progress and expenditure reports to CAREs Science and Funding Committee. Grants are restricted for the specified research purposes, with no more than 25% of funds allocated to labor and benefit costs.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $930,112

Program Service Revenue $0

Investment Income $11,478

Other Revenue $-73,826

TOTAL REVENUE $867,764

Expense Breakdown

Grants Paid $748,000

Salaries & Benefits $95,368

Fundraising Expenses $18,555

Program Expenses $748,000

Other Expenses $38,235

TOTAL EXPENSES $881,603

Year-over-Year Comparison

	2024	2023	Change
Revenue	$867,764	$869,722	0.0%
Expenses	$881,603	$954,535	-0.1%
Net Income	$-13,839	$-84,813	-0.8%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Michael Blaszyk	Director	15.00	Director	$0	$0	$0
Syliva Owens	Director	2.00	Director	$0	$0	$0
Amanda Bruen	Director	3.00	Director	$0	$0	$0
Mary Wendt Moase	Director	12.00	Director	$0	$0	$0
Jill Porcellato	Chairman	30.00	Officer	$0	$0	$0
J DEREK HILL	Treasurer	10.00	Officer	$0	$0	$0
Regina Ryan	Secretary	2.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$867,764	$881,603	$86,259	$-13,839
2024	$869,722	$954,535	$100,098	$-84,813
2023	$871,517	$835,059	$184,911	$36,458
2022	$969,135	$905,955	$148,453	$63,180
2021	$538,326	$520,757	$85,272	$17,569
2020	$692,723	$640,202	$83,702	$52,521
2019	$527,030	$534,053	$27,871	$-7,023
2018	$592,193	$590,392	$34,894	$1,801

CANCER AWARENESS THROUGH RESEARCH AND EDUCATION CARE